A Novel ACT-based Video Game
A Novel ACT-based Video Game to Support Mental Health Through Embedded Learning: A Mixed-methods Feasibility Study Protocol
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wales
-
Swansea, Wales, United Kingdom, SA28PP
- Swansea University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults reporting some existing form of anxiety, depression or ongoing stress.
- Need ability to read and write English.
- Need internet access to play the videogame.
Exclusion Criteria:
- Those who are under 18
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: ACT video game
|
The intervention is a videogame which teaches the participant about acceptance and commitment therapy.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants recruited for the study
Time Frame: 3 Weeks
|
Feasibility outcome for recruitment.
|
3 Weeks
|
|
Number of participants who completed all aspects of the study
Time Frame: 3 Weeks
|
Feasibility outcome for retention of participants.
|
3 Weeks
|
|
Reflexive thematic analysis themes
Time Frame: 3 Weeks; Immediate post intervention, and 3-week follow-up
|
Acceptability of the intervention assessed through qualitative analysis of semi-structured interviews.
|
3 Weeks; Immediate post intervention, and 3-week follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression Anxiety Stress Scale-21 (Depression subscale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Quantitative psychometric measure for depression.
Score Range: Min=0, Max=21.
Higher scores indicate higher depression.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
Depression Anxiety Stress Scale-21 (Anxiety subscale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Quantitative psychometric measure for anxiety.
Score Range: Min=0, Max=21.
Higher scores indicate higher anxiety.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
Depression Anxiety Stress Scale-21 (Stress subscale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Quantitative psychometric measure for stress.
Score Range: Min=0, Max=21.
Higher score indicate higher stress.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
Acceptance and Action Questionnaire- second version
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Quantitative psychometric measure for psychological inflexibility.
Score Range: Min=7, Max=49.
Higher scores indicate higher psychological inflexibility.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
Social Connectedness (adapted from Russell's (1996) University of California, Los Angeles Loneliness Scale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Quantitative psychometric measure of Social Connectedness.
Score range: Min=2, Max=8.
Higher scores indicate higher social connectedness.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
Warwick-Edinburgh Mental Well-Being Scale
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Quantitative psychometric measure of mental well-being with a focus on positive aspects of mental health.
Score Range: Min=14, Max=70.
Higher scores indicate higher wellbeing.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
EuroQol five dimensions (Mobility Subscale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Score Range: Min=1, Max=5.
Higher scores indicate lower mobility.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
EuroQol five dimensions (Self-care Subscale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Score Range: Min=1, Max=5.
Higher scores indicate lower self-care.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
EuroQol five dimensions (Usual Activities Subscale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Score Range: Min=1, Max=5.
Higher scores indicate lower partaking in usual activities.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
EuroQol five dimensions (Pain/Discomfort Subscale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Score Range: Min=1, Max=5.
Higher scores indicate lower pain/discomfort.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
EuroQol five dimensions (Anxiety/Depression Subscale)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Score Range: Min=1, Max=5.
Higher scores indicate lower anxiety/depression.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
|
EuroQol five dimensions (Score to indicate how health is today)
Time Frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Score Range: Min=0, Max=100.
Higher scores indicate higher health.
|
3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Swansea U1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.